anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

187,321-187,380 of 319,975

filter-aware
11
The slide highlights the achievement of critical mass at 10M+ genetic profiles.23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
12
The slide uses a circular process diagram to represent a self-reinforcing business model.23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
13
The slide highlights the consumer-facing features that drive data collection for their research database.23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
14
Uses a flow diagram to show the gap in current healthcare screening criteria.23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
15
The slide uses a structured 4-column layout to categorize product offerings, each paired with a representative mobile app screenshot.23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations Beat · Solution1 hit
16
The slide uses screenshots of a mobile app to demonstrate the 'fun' aspect of the data collection process.23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
17
The slide highlights the value proposition of the premium subscription tier.23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
18
The slide features a background pattern of DNA base pairs (A, T, C, G) and a circular '3' icon, suggesting it is the third section of the deck.23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
19
The slide uses a classic NEJM citation to frame the problem of healthcare over-reliance.23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
20
The slide uses a gradient background on the left and a bar chart on the right to visualize survey results.23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
21
Uses a before-after-framing structure to contrast current industry standards with the company's value proposition.23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
22
The slide uses a process-flow style diagram to show how the combined entities enable six specific service offerings.23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
23
23andMe | Investor Presentation Deck | 58 slides23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
24
The slide uses a horizontal flow to illustrate integration across the service lifecycle.23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
25
The slide features a DNA-themed background with scattered nucleotide letters (A, C, T, G) and a prominent '4' in a circle, likely indicating a section number.23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
26
The slide uses a split-screen layout with a blue background on the left for the core problem statement and a white background on the right for supporting metrics.23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
27
The slide uses a split-screen layout with a white background for data and a magenta background for the thesis statement.23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
28
The slide highlights both the breadth of the participant pool and the speed of research execution.23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
29
Includes a Manhattan plot visualization and a zoomed-in regional association plot.23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
30
The slide uses Manhattan plots to visualize genetic associations over time (2016, 2017, 2021) and a line chart to show the growth of independent hits from 2015 to 2020.23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
31
The slide uses a grid of small-multiple charts to demonstrate breadth, with a specific callout for NAFLD at the bottom.23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
32
The slide uses Manhattan plots to show genetic associations linked to specific proteins in the TSLP pathway.23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
33
The slide uses a timeline-style bar chart to show clinical progress for two lead assets and a summary metric for early-stage programs.23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
34
The slide uses a heatmap to demonstrate how genetic signals correlate with various phenotypes, specifically highlighting a rare disease.23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
35
The slide uses a funnel metaphor to show the refinement of data into drug targets.23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
36
23andMe | Investor Presentation Deck | 58 slides23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
37
The slide uses a three-step process flow (Market -> Methodology -> Discovery).23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
38
23andMe | Investor Presentation Deck | 58 slides23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
39
The slide uses heatmaps to demonstrate genetic correlations with various phenotypes, highlighting the discovery of a signaling pathway.23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
40
The slide uses a biological pathway diagram to illustrate the mechanism of action.23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
41
The slide uses a before-and-after diagram to illustrate the mechanism of action.23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
42
The slide uses a scatter plot to demonstrate a positive correlation (rho = 0.86) between CD200R1 and CD45 in KIRC (Clear cell renal carcinoma) samples.23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
43
The chart demonstrates efficacy of the drug candidate 23ME '610 in an ex vivo assay.23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
44
The slide outlines a standard clinical trial structure with patient inclusion criteria, study arms (Part A/B), and primary/secondary endpoints.23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
45
23andMe | Investor Presentation Deck | 58 slides23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
46
23andMe | Investor Presentation Deck | 58 slides23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
47
23andMe | Investor Presentation Deck | 58 slides23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
48
The background features a DNA-like pattern of nucleotides (A, T, C, G).23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations Beat · Financials1 hit
49
The slide uses a numbered list to communicate three strategic pillars.23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
50
The table provides both absolute dollar amounts in millions and percentage of total revenue for each segment.23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
51
Fiscal year ends March 31.23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
52
23andMe | Investor Presentation Deck | 58 slides23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
53
The table breaks down S&M costs into five categories: Advertising/Brand, Personnel, Outside Services, D&A, and Facilities/OH.23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
54
Fiscal year ends March 31.23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
55
The slide uses a '+' notation to illustrate the integration of services.23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
56
The background contains a scattered pattern of DNA nucleotides (A, T, C, G).23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
57
Uses a 'fill in the blanks' analogy to explain genetic imputation.23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
58
The slide uses a numbered list format to outline key strategic pillars.23andMe | Investor Presentation Deck | 58 slides · 23andMe
Pitch deck Investor relations 1 hit
01
Slide 1
AbCellera | Results Presentation Deck | 17 slidesAbCellera | Results Presentation Deck | 17 slides · AbCellera
Conference presentation Investor relations Beat · Setup1 hit
02
AbCellera | Results Presentation Deck | 17 slidesAbCellera | Results Presentation Deck | 17 slides · AbCellera
Conference presentation Investor relations Beat · Setup1 hit
03
The slide uses a three-column layout to present strategic pillars alongside key performance metrics.AbCellera | Results Presentation Deck | 17 slides · AbCellera
Conference presentation Investor relations Beat · Setup1 hit
04
The slide uses a timeline-like structure to emphasize the multi-year duration and complexity of the drug development process.AbCellera | Results Presentation Deck | 17 slides · AbCellera
Conference presentation Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
05
AbCellera | Results Presentation Deck | 17 slidesAbCellera | Results Presentation Deck | 17 slides · AbCellera
Conference presentation Investor relations Beat · Key TakeawaysLoop · Cost Of Inaction1 hit
06
The slide highlights two specific VC partners: Atlas Venture and Versant Ventures, showing program counts and target metrics.AbCellera | Results Presentation Deck | 17 slides · AbCellera
Conference presentation Investor relations Beat · KPI Overview1 hit
07
The slide uses a gradient-filled callout box to emphasize the proof-of-concept results.AbCellera | Results Presentation Deck | 17 slides · AbCellera
Conference presentation Investor relations Beat · KPI OverviewLoop · Golden Circle1 hit
08
The slide uses a three-column layout to categorize different technology platforms, each with a brief description of its strategic value.AbCellera | Results Presentation Deck | 17 slides · AbCellera
Conference presentation Investor relations Beat · KPI OverviewLoop · Golden Circle1 hit
09
The slide uses a high-contrast green-on-dark-blue color scheme to emphasize key metrics.AbCellera | Results Presentation Deck | 17 slides · AbCellera
Conference presentation Investor relations Beat · KPI OverviewLoop · Golden Circle1 hit
10
AbCellera | Results Presentation Deck | 17 slidesAbCellera | Results Presentation Deck | 17 slides · AbCellera
Conference presentation Investor relations Beat · KPI Overview1 hit
11
The slide uses a stacked bar chart to distinguish between programs with and without downstream participation.AbCellera | Results Presentation Deck | 17 slides · AbCellera
Conference presentation Investor relations Beat · KPI Overview1 hit
12
The slide provides a snapshot of the company's clinical pipeline as of June 30, 2022.AbCellera | Results Presentation Deck | 17 slides · AbCellera
Conference presentation Investor relations Beat · KPI Overview1 hit